secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001493152-23-039180
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma shareholders approve reverse stock split and reelect directors
--------------------------------------------------------------------------------

- All 7 director nominees elected; Eric Ende received 57.9M for, 10.1M withheld; 59.1M broker non-votes.
- Say-on-pay proposal approved: 53.3M for, 12.0M against, 2.7M abstain.
- Ratification of EisnerAmper as auditor passed: 121.9M for, 3.1M against, 2.1M abstain.
- Amendment to effect reverse stock split (1:2 to 1:50) and reduce authorized shares to 250M approved: 93.0M for, 31.1M against.
- Total shares represented at meeting: 127.1M, or 58.5% of outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315223039180/0001493152-23-039180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315223039180/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer